{"id":1670,"date":"2023-06-25T17:29:32","date_gmt":"2023-06-25T17:29:32","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/betaxolol-hydrochloride\/"},"modified":"2023-06-25T19:49:57","modified_gmt":"2023-06-25T19:49:57","slug":"betaxolol-hydrochloride","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/betaxolol-hydrochloride\/","title":{"rendered":"Betaxolol hydrochloride"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Betaxolol hydrochloride.JPG\"><\/p>\n<h1>Betaxolol hydrochloride<\/h1>\n<h3>  CLINICAL USE<\/h3>\n<p>Hyperlipidaemia<\/p>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<p>200 mg, 3 times a day Modified release: 400 mg daily<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :361.8<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :95<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; : 50<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; :0.24\u20130.35<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; :1\u20132 (XL: 3.4)\/7.8\u201320<br \/>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<p>40\u201360 400 mg daily15\u201340 200 mg every 24\u201348 hours&lt;15 Avoid<\/p>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:Not dialysed. 200 mg every 72 hours<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :Not dialysed. 200 mg every 72 hours<\/li>\n<li>HDF\/high flux  &nbsp; :Unknown dialysability. 200 mg every 72 hours<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;:Unknown dialysability. Dose as in GFR=15\u201340 mL\/min<br \/>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugsAntibacterials: increased risk of  myopathy with daptomycin \u2013 try to avoid concomitant useAnticoagulants: enhances effect of  coumarins and phenindione; dose of anticoagulant should be reduced by up to 50% and adjusted by monitoring INRAntidiabetics: may improve glucose  tolerance and have an additive effect with insulin or sulphonylureasCiclosporin: may increase nephrotoxicity  and reduce ciclosporin levelsLipid-regulating drugs: increased risk of  myopathy in combination with statins and ezetimibe \u2013 avoid with ezetimibe; do not exceed 10 mg of simvastatin1<\/p>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>\u2013<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<p>Take dose with or after food Contraindicated in nephrotic syndrome There should be an interval of 2 hours  between intake of ion exchange resin and bezafibrateModified-release preparation is not  appropriate in renal impairment<\/li>\n","protected":false},"excerpt":{"rendered":"<p>Betaxolol hydrochloride CLINICAL USE Hyperlipidaemia DOSE IN NORMAL RENAL FUNCTION<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-1670","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=1670"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1670\/revisions"}],"predecessor-version":[{"id":2890,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1670\/revisions\/2890"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=1670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=1670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=1670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}